Literature DB >> 31324932

[Long-term effects of cisplatin-based chemotherapy in testicular cancer patients-what is important?]

Walter Albrecht1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31324932     DOI： 10.1007/s00120-019-1000-8

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  8 in total

1.  Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.

Authors:  A D Vidal; G N Thalmann; E Karamitopoulou-Diamantis; M F Fey; U E Studer
Journal:  Ann Oncol       Date:  2014-11-12       Impact factor: 32.976

2.  The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study.

Authors:  Allan Ben Smith; Phyllis Butow; Ian Olver; Tim Luckett; Peter Grimison; Guy C Toner; Martin R Stockler; Elizabeth Hovey; John Stubbs; Sandra Turner; George Hruby; Howard Gurney; Mahmood Alam; Keith Cox; Madeleine T King
Journal:  J Cancer Surviv       Date:  2015-07-16       Impact factor: 4.442

3.  Primary prevention of cardiovascular disease with a Mediterranean diet.

Authors:  Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel Angel Muñoz; José V Sorlí; José Alfredo Martínez; Miguel Angel Martínez-González
Journal:  N Engl J Med       Date:  2013-02-25       Impact factor: 91.245

4.  Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment.

Authors:  Ali Amidi; Mads Agerbæk; Lisa M Wu; Anders D Pedersen; Mimi Mehlsen; Cecilie R Clausen; Ditte Demontis; Anders D Børglum; Anja Harbøll; Robert Zachariae
Journal:  Brain Imaging Behav       Date:  2017-06       Impact factor: 3.978

5.  Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score.

Authors:  Darren R Feldman; Shirin Ardeshir-Rouhani-Fard; Patrick Monahan; Howard D Sesso; Chunkit Fung; Annalynn M Williams; Robert J Hamilton; David J Vaughn; Clair J Beard; Ryan Cook; Mohammad Abu Zaid; Steven E Lipshultz; Lawrence H Einhorn; Kevin C Oeffinger; Lois B Travis; Sophie D Fossa
Journal:  Clin Genitourin Cancer       Date:  2018-02-05       Impact factor: 2.872

6.  Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome.

Authors:  C Bogefors; S Isaksson; J Bobjer; M Kitlinski; I Leijonhufvud; K Link; A Giwercman
Journal:  Andrology       Date:  2017-05-23       Impact factor: 3.842

7.  Effect of Bleomycin Administration on the Development of Pulmonary Toxicity in Patients With Metastatic Germ Cell Tumors Receiving First-Line Chemotherapy: A Meta-Analysis of Randomized Studies.

Authors:  Andrea Necchi; Rosalba Miceli; Karima Oualla; Guru Sonpavde; Patrizia Giannatempo; Daniele Raggi; Nicola Nicolai; Roberto Boffi; Alessandra Busia; Luigi Mariani; Roberto Salvioni
Journal:  Clin Genitourin Cancer       Date:  2016-09-08       Impact factor: 2.872

8.  Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors.

Authors:  Line V Hjelle; Per O M Gundersen; Ragnhild Hellesnes; Mette Sprauten; Marianne Brydøy; Torgrim Tandstad; Tom Wilsgaard; Sophie D Fosså; Jan Oldenburg; Roy M Bremnes; Hege S Haugnes
Journal:  Acta Oncol       Date:  2018-05-18       Impact factor: 4.089
  8 in total
  2 in total

1.  Upregulation of microRNA-181a-5p increases the sensitivity of HS578T breast cancer cells to cisplatin by inducing vitamin D receptor-mediated cell autophagy.

Authors:  Jianmin Lin; Xuming Chen; Mingliang Sun; Xiaojiao Qu; Ye Wang; Chenxi Li; Xiujuan Li; Li Zhao; Zhiying Su; Huiming Ye
Journal:  Oncol Lett       Date:  2021-02-03       Impact factor: 2.967

2.  [Using preorchiectomy tumor marker serum concentrations for International Germ Cell Consensus Classification (IGCCCG) risk group assignment results in significant numbers of up- and downstaging].

Authors:  Pia Paffenholz; Tim Nestler; Yasmine Maatoug; Melanie von Brandenstein; Barbara Köditz; David Pfister; Axel Heidenreich
Journal:  Urologe A       Date:  2021-01-11       Impact factor: 0.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.